The Global Fund allocates funding to countries to support HIV, TB and malaria programs and to build resilient and sustainable systems for health. These allocations are made every three years at the beginning of a new funding period.
The total amount available for allocations to countries depends on the funding raised during the corresponding three-year Replenishment cycle.
Allocations to individual countries are calculated using a formula that is predominantly based on each country’s disease burden and economic capacity. They are refined to account for important contextual factors through a transparent and accountable qualitative adjustment process.
The Global Fund refined the allocation methodology for 2023-2025 to be prepared for the higher funding requested for the Seventh Replenishment, which asks for at least US$18 billion to get back on track towards ending HIV, TB and malaria.
The 2023-2025 methodology drives funding to higher burden, lower income countries, specifically accounting for HIV epidemics among key and vulnerable populations, the threat of multidrug-resistant TB and the risk of malaria resurgence. Where a decrease in funding is planned, the methodology provides sustainable and paced reductions. In the case of a successful Replenishment, a greater percentage of funds will be allocated to TB programs, in line with the severe impact that COVID-19 has had on the fight against TB.